Q. A 42-year-old woman presents with enlarged hands, coarsened facial features, and an increased shoe size. Her IGF-1 level is elevated. Which of the following is the most specific test to confirm the diagnosis?

Explanation

## Correct Answer: A. Lack of GH suppression following oral glucose tolerance test (OGTT) The clinical presentation of enlarged hands, coarsened facial features, and increased shoe size in a 42-year-old woman is pathognomonic for **acromegaly**, caused by excessive growth hormone (GH) secretion, typically from a pituitary adenoma. While elevated IGF-1 supports the diagnosis, the **gold standard confirmatory test is the oral glucose tolerance test (OGTT) with GH measurement**. In healthy individuals, glucose intake suppresses GH secretion to <1 ng/mL within 30–60 minutes. In acromegaly, GH fails to suppress appropriately (remains >1 ng/mL), making this the most specific diagnostic criterion. This lack of GH suppression distinguishes acromegaly from other causes of elevated IGF-1 and confirms autonomous GH hypersecretion. Per Indian endocrinology guidelines and Harrison's criteria, OGTT-based GH suppression is the diagnostic gold standard because it demonstrates the pathophysiologic hallmark: loss of normal feedback inhibition. IGF-1 elevation alone is sensitive but not specific (seen in malnutrition recovery, puberty, pregnancy, and other conditions); random GH levels are unreliable due to pulsatile secretion; and IGF-1 suppression after OGTT is not a recognized diagnostic criterion for acromegaly. ## Why the other options are wrong **B. Random growth hormone level** — GH is secreted in a pulsatile manner with significant fluctuations throughout the day. A single random GH measurement is unreliable and non-specific for acromegaly diagnosis. Patients may have normal random GH levels despite active disease, making this test insensitive. The diagnostic value lies in GH *response* to a suppressive stimulus (glucose), not baseline levels. **C. Lack of IGF-1 suppression after OGTT** — IGF-1 suppression after OGTT is not a recognized diagnostic criterion for acromegaly. The diagnostic test focuses on GH suppression, not IGF-1 suppression. Additionally, IGF-1 has a long half-life (~15–20 hours) and does not suppress acutely after glucose intake like GH does, making this test neither specific nor practical for diagnosis. **D. Measurement of IGF-1 alone** — Elevated IGF-1 is sensitive for acromegaly but lacks specificity. IGF-1 elevation occurs in normal puberty, pregnancy, malnutrition recovery, and other non-pathological states. IGF-1 measurement alone cannot distinguish acromegaly from these conditions. Diagnosis requires demonstrating autonomous GH hypersecretion via the OGTT suppression test, which is the gold standard. ## High-Yield Facts - **OGTT with GH suppression <1 ng/mL is the gold standard diagnostic test for acromegaly**; failure to suppress confirms autonomous GH secretion. - **IGF-1 elevation is sensitive but not specific** for acromegaly; it rises in puberty, pregnancy, and malnutrition recovery. - **Pulsatile GH secretion** makes random GH levels unreliable; diagnostic value lies in GH *response* to suppressive stimuli. - **Acromegaly diagnosis requires both elevated IGF-1 AND lack of GH suppression on OGTT**; either criterion alone is insufficient. - **MRI pituitary is the imaging modality of choice** to localize the adenoma after biochemical confirmation in Indian clinical practice. ## Mnemonics **OGTT for Acromegaly Diagnosis** **O**GTT **G**lucose **T**est: **G**rowth hormone should **S**uppress <1 ng/mL. **Lack of suppression = Acromegaly confirmed.** Use when biochemical suspicion is high (elevated IGF-1 + clinical features). **Why Not Random GH?** **P**ulsatile **G**rowth hormone secretion = **P**oor reliability of **R**andom levels. Always need a **S**uppression **T**est (OGTT) for diagnosis. ## NBE Trap NBE pairs elevated IGF-1 with "measurement of IGF-1 alone" to trap students who confuse sensitivity (IGF-1 is elevated in acromegaly) with specificity (IGF-1 is also elevated in many non-pathological states). The discriminating feature of acromegaly is *autonomous* GH secretion, which only OGTT suppression testing reveals. ## Clinical Pearl In Indian clinical practice, a 40–50-year-old patient presenting with progressive hand/foot enlargement and coarse features is acromegaly until proven otherwise. Always confirm with OGTT-based GH suppression before initiating expensive imaging or treatment; many patients with elevated IGF-1 are misdiagnosed without this test. _Reference: Harrison Ch. 375 (Disorders of Growth Hormone Secretion); Robbins Ch. 24 (Endocrine System)_